Esketamine, a drug developed by Johnson & Johnson for the treatment of depression has received support from two FDA committees. Final FDA approval is expected by...
Depression research study participants needed to take part in several clinical research trials exploring the effects of rapastinel, esketamine, and ketamine like compounds. Generally, research...
